What's New

• RCO Updates [05/2025]
• Ancillary and Institutional Reviews [5/2025]
• Data Scraping guidance that includes considerations for research teams that are using data scraping as a research method. [03/2025]
• Updated Short Form Consent Process Guidance:
  • Witness should be impartial and fluent in both English and the language of the participant [01/2025]
  • Translated consent form required after the short form consent process for certain studies involving investigational biologics, drugs, and/or devices [02/2024]
• Expedited and exempt IRB protocol applications that have no expiration date (i.e., do not require annual review) will receive a notification to confirm the status of the study three (3) years after the last action taken. If no response, the study will be administratively closed by the IRB. [12/2024]
• Can I use the Chart Review Form? [08/2024]
• What should I consider when doing focus group research? [08/2024]
• IRB Turnaround Times and Customer Satisfaction Survey Results are published quarterly and annually based on the Panel Year (October 1 – September 30). [07/2024]
• Updated Pregnant Partner guidance.  This guidance outlines why pregnant partners, and their fetus/child, are not human subject research participants when their involvement is limited to collection of safety data. [07/2024]
• When is a Data Risk Assessment (DRA) needed? [05/2024]
• Medical children assent forms have been separated into two documents for ages 13-17 and ages 7-12. [03/2024]
• Medical consent templates have been translated into Spanish. [02/2024]

Office Hours

The IRB is offering office hours for Non-medical and single IRB (sIRB) related questions; see below table for more information.  If you would like to schedule a meeting outside of the scheduled office hours, contact the below respective email address.

• About the IRB (the Administrative Panels on Human Subjects Research)
• Charge to the IRBs